Bio-Rad Wins Order Excluding Competitor's Gene Sequencing Technology Products
A Weil team persuaded U.S. District Judge Richard Andrews to enjoin 10x Genomics from marketing six products that infringe patents developed by the University of Chicago.
July 24, 2019 at 07:32 PM
3 minute read
Bio-Rad Laboratories Inc. has won an injunction excluding competitor 10x Genomics Inc. from marketing products that perform genetic analysis on a single-cell droplet platform.
Wednesday's decision from U.S. District Judge Richard Andrews of the District of Delaware follows a jury trial last fall that ended in a $24 million patent infringement award for Hercules, California-based Bio-Rad and the University of Chicago, from whom it licenses the patents. 10X managed to turn back Bio-Rad's request for enhanced damages and attorney fees.
According to Andrews' opinion, Pleasanton, California-based 10X's single-cell products account for more than 80% of its sales. Bio-Rad and the university “have shown that they will suffer irreparable competitive harm absent an injunction,” Andrews wrote. ”Plaintiffs are being forced to compete with 10x's products that incorporate and infringe their own patented inventions.”
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Trending Stories
- 1Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 2The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 3The 'Biden Effect' on Senior Attorneys: Should I Stay or Should I Go?
- 4BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 5'You Are Not Alone': 120 Sex Assault Victims Plan to Sue Sean 'Diddy' Combs
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250